Report Detail
Global Bacterial Vaginosis Drugs Market Research Report 2019
- RnM3123032 |
- 14 March, 2019 |
- Global |
- 99 Pages |
- QYResearch |
- Pharma & Healthcare
Bacterial vaginosis is an imbalance of "good" and "bad" bacteria in the vagina, with there being more bad bacteria. Causes of an imbalance of bacteria can be caused by multiple sex partners and douching. Symptoms include odor, discharge, burning, and itching. Treatments for bacterial vaginosis include the use of probiotics and medication. Common drug classes include lincosamide antibiotics and nitroimidazole antibiotics.
One driver in the market is unmet demand in BV treatment market. Unmet demand in the treatment of BV has created great opportunity for the market players. There is huge unmet need in the treatment of BV, especially the recurrent form of the disease. BV is the most common vaginal infection in the women of child bearing age group. Despite being highly prevalent in nature, little has been done in the field. When left untreated, it may lead to severe infections, especially in the case of pregnant women such as preterm births. rising awareness about women's health as one of the primary growth factors for the bacterial vaginosis drugs market. Owing to recent advancements in healthcare and the initiatives taken by the government and non-government organizations to increase the awareness about health of women, the demand for pharmaceuticals related to disorders in women will witness a significant increase in the coming years. Additionally, support from government is also a key driver.
The global Bacterial Vaginosis Drugs market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Bacterial Vaginosis Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Bacterial Vaginosis Drugs market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Bayer
Pfizer
Sanofi
Starpharma Holdings
...
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Oral
Topical
Segment by Application
Pelvic Inflammatory Disease
Preterm Delivery of Infants
Urinary Tract Infection
Sexually Transmitted Diseases (STD)
Table of Contents
Executive Summary
1 Bacterial Vaginosis Drugs Market Overview
- 1.1 Product Overview and Scope of Bacterial Vaginosis Drugs
- 1.2 Bacterial Vaginosis Drugs Segment by Type
- 1.2.1 Global Bacterial Vaginosis Drugs Production Growth Rate Comparison by Type (2014-2025)
- 1.2.2 Oral
- 1.2.3 Topical
- 1.3 Bacterial Vaginosis Drugs Segment by Application
- 1.3.1 Bacterial Vaginosis Drugs Consumption Comparison by Application (2014-2025)
- 1.3.2 Pelvic Inflammatory Disease
- 1.3.3 Preterm Delivery of Infants
- 1.3.4 Urinary Tract Infection
- 1.3.5 Sexually Transmitted Diseases (STD)
- 1.4 Global Bacterial Vaginosis Drugs Market by Region
- 1.4.1 Global Bacterial Vaginosis Drugs Market Size Region
- 1.4.2 North America Status and Prospect (2014-2025)
- 1.4.3 Europe Status and Prospect (2014-2025)
- 1.4.4 China Status and Prospect (2014-2025)
- 1.4.5 Japan Status and Prospect (2014-2025)
- 1.5 Global Bacterial Vaginosis Drugs Market Size
- 1.5.1 Global Bacterial Vaginosis Drugs Revenue (2014-2025)
- 1.5.2 Global Bacterial Vaginosis Drugs Production (2014-2025)
2 Global Bacterial Vaginosis Drugs Market Competition by Manufacturers
- 2.1 Global Bacterial Vaginosis Drugs Production Market Share by Manufacturers (2014-2019)
- 2.2 Global Bacterial Vaginosis Drugs Revenue Share by Manufacturers (2014-2019)
- 2.3 Global Bacterial Vaginosis Drugs Average Price by Manufacturers (2014-2019)
- 2.4 Manufacturers Bacterial Vaginosis Drugs Production Sites, Area Served, Product Types
- 2.5 Bacterial Vaginosis Drugs Market Competitive Situation and Trends
- 2.5.1 Bacterial Vaginosis Drugs Market Concentration Rate
- 2.5.2 Bacterial Vaginosis Drugs Market Share of Top 3 and Top 5 Manufacturers
- 2.5.3 Mergers & Acquisitions, Expansion
3 Global Bacterial Vaginosis Drugs Production Market Share by Regions
- 3.1 Global Bacterial Vaginosis Drugs Production Market Share by Regions
- 3.2 Global Bacterial Vaginosis Drugs Revenue Market Share by Regions (2014-2019)
- 3.3 Global Bacterial Vaginosis Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 3.4 North America Bacterial Vaginosis Drugs Production
- 3.4.1 North America Bacterial Vaginosis Drugs Production Growth Rate (2014-2019)
- 3.4.2 North America Bacterial Vaginosis Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 3.5 Europe Bacterial Vaginosis Drugs Production
- 3.5.1 Europe Bacterial Vaginosis Drugs Production Growth Rate (2014-2019)
- 3.5.2 Europe Bacterial Vaginosis Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 3.6 China Bacterial Vaginosis Drugs Production (2014-2019)
- 3.6.1 China Bacterial Vaginosis Drugs Production Growth Rate (2014-2019)
- 3.6.2 China Bacterial Vaginosis Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 3.7 Japan Bacterial Vaginosis Drugs Production (2014-2019)
- 3.7.1 Japan Bacterial Vaginosis Drugs Production Growth Rate (2014-2019)
- 3.7.2 Japan Bacterial Vaginosis Drugs Production, Revenue, Price and Gross Margin (2014-2019)
4 Global Bacterial Vaginosis Drugs Consumption by Regions
- 4.1 Global Bacterial Vaginosis Drugs Consumption by Regions
- 4.2 North America Bacterial Vaginosis Drugs Consumption (2014-2019)
- 4.3 Europe Bacterial Vaginosis Drugs Consumption (2014-2019)
- 4.4 China Bacterial Vaginosis Drugs Consumption (2014-2019)
- 4.5 Japan Bacterial Vaginosis Drugs Consumption (2014-2019)
5 Global Bacterial Vaginosis Drugs Production, Revenue, Price Trend by Type
- 5.1 Global Bacterial Vaginosis Drugs Production Market Share by Type (2014-2019)
- 5.2 Global Bacterial Vaginosis Drugs Revenue Market Share by Type (2014-2019)
- 5.3 Global Bacterial Vaginosis Drugs Price by Type (2014-2019)
- 5.4 Global Bacterial Vaginosis Drugs Production Growth by Type (2014-2019)
6 Global Bacterial Vaginosis Drugs Market Analysis by Applications
- 6.1 Global Bacterial Vaginosis Drugs Consumption Market Share by Application (2014-2019)
- 6.2 Global Bacterial Vaginosis Drugs Consumption Growth Rate by Application (2014-2019)
7 Company Profiles and Key Figures in Bacterial Vaginosis Drugs Business
- 7.1 Bayer
- 7.1.1 Bayer Bacterial Vaginosis Drugs Production Sites and Area Served
- 7.1.2 Bacterial Vaginosis Drugs Product Introduction, Application and Specification
- 7.1.3 Bayer Bacterial Vaginosis Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.1.4 Main Business and Markets Served
- 7.2 Pfizer
- 7.2.1 Pfizer Bacterial Vaginosis Drugs Production Sites and Area Served
- 7.2.2 Bacterial Vaginosis Drugs Product Introduction, Application and Specification
- 7.2.3 Pfizer Bacterial Vaginosis Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.2.4 Main Business and Markets Served
- 7.3 Sanofi
- 7.3.1 Sanofi Bacterial Vaginosis Drugs Production Sites and Area Served
- 7.3.2 Bacterial Vaginosis Drugs Product Introduction, Application and Specification
- 7.3.3 Sanofi Bacterial Vaginosis Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.3.4 Main Business and Markets Served
- 7.4 Starpharma Holdings
- 7.4.1 Starpharma Holdings Bacterial Vaginosis Drugs Production Sites and Area Served
- 7.4.2 Bacterial Vaginosis Drugs Product Introduction, Application and Specification
- 7.4.3 Starpharma Holdings Bacterial Vaginosis Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.4.4 Main Business and Markets Served
8 Bacterial Vaginosis Drugs Manufacturing Cost Analysis
- 8.1 Bacterial Vaginosis Drugs Key Raw Materials Analysis
- 8.1.1 Key Raw Materials
- 8.1.2 Price Trend of Key Raw Materials
- 8.1.3 Key Suppliers of Raw Materials
- 8.2 Proportion of Manufacturing Cost Structure
- 8.3 Manufacturing Process Analysis of Bacterial Vaginosis Drugs
- 8.4 Bacterial Vaginosis Drugs Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
- 9.1 Marketing Channel
- 9.1.1 Direct Marketing
- 9.1.2 Indirect Marketing
- 9.2 Bacterial Vaginosis Drugs Distributors List
- 9.3 Bacterial Vaginosis Drugs Customers
10 Market Dynamics
- 10.1 Market Trends
- 10.2 Opportunities
- 10.3 Market Drivers
- 10.4 Challenges
- 10.5 Influence Factors
11 Global Bacterial Vaginosis Drugs Market Forecast
- 11.1 Global Bacterial Vaginosis Drugs Production, Revenue Forecast
- 11.1.1 Global Bacterial Vaginosis Drugs Production Growth Rate Forecast (2019-2025)
- 11.1.2 Global Bacterial Vaginosis Drugs Revenue and Growth Rate Forecast (2019-2025)
- 11.1.3 Global Bacterial Vaginosis Drugs Price and Trend Forecast (2019-2025)
- 11.2 Global Bacterial Vaginosis Drugs Production Forecast by Regions (2019-2025)
- 11.2.1 North America Bacterial Vaginosis Drugs Production, Revenue Forecast (2019-2025)
- 11.2.2 Europe Bacterial Vaginosis Drugs Production, Revenue Forecast (2019-2025)
- 11.2.3 China Bacterial Vaginosis Drugs Production, Revenue Forecast (2019-2025)
- 11.2.4 Japan Bacterial Vaginosis Drugs Production, Revenue Forecast (2019-2025)
- 11.3 Global Bacterial Vaginosis Drugs Consumption Forecast by Regions (2019-2025)
- 11.3.1 North America Bacterial Vaginosis Drugs Consumption Forecast (2019-2025)
- 11.3.2 Europe Bacterial Vaginosis Drugs Consumption Forecast (2019-2025)
- 11.3.3 China Bacterial Vaginosis Drugs Consumption Forecast (2019-2025)
- 11.3.4 Japan Bacterial Vaginosis Drugs Consumption Forecast (2019-2025)
- 11.4 Global Bacterial Vaginosis Drugs Production, Revenue and Price Forecast by Type (2019-2025)
- 11.5 Global Bacterial Vaginosis Drugs Consumption Forecast by Application (2019-2025)
12 Research Findings and Conclusion
13 Methodology and Data Source
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Bacterial Vaginosis Drugs . Industry analysis & Market Report on Bacterial Vaginosis Drugs is a syndicated market report, published as Global Bacterial Vaginosis Drugs Market Research Report 2019. It is complete Research Study and Industry Analysis of Bacterial Vaginosis Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
